Skip to main content

and
  1. No Access

    Article

    Trajectory of COVID-19 response and management strategy in China: scientific rationale driven strategy adjustments

    The pneumonia caused by novel coronavirus SARS-CoV-2 infection in early December 2019, which was later named coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO), rapidly spread across th...

    Zeyu Zhang, Yue Yan, Lina Zhao, Yizhou Bian, Ning Zhao, You Wu in Frontiers of Medicine (2024)

  2. Article

    Revisiting China’s response to coronavirus disease 2019

    Guangbiao Zhou, Saijuan Chen, Zongjiu Zhang, Zhu Chen in Frontiers of Medicine (2023)

  3. Article

    Open Access

    A nationwide telepathology consultation and quality control program in China: implementation and result analysis

    Telepathology may play an important role in pathology consultation and quality control for cancer diagnosis in China, as the country has the largest population of cancer patients worldwide. In 2011, the Pathol...

    Je Chen, Yahui Jiao, Chaohui Lu, Jun Zhou, Zongjiu Zhang, Chen Zhou in Diagnostic Pathology (2014)